The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
It is. I bought more yesterday so will leave it at that for now. Good price now though!
Someone has a short to close? PANIC!!
I can see no news also dropping the sp, thats why faron must issue an update, even if it is just to say things are going well but they need a few more months. Staying quiet when people expect something would not be good.
After watching the interview with the ceo, he said something along the line that everything will be clearer by the summer. Can’t recall the exact words without re watching the interview. Do we reckon we may have to wait for an update on YODA until the summer? Or would they issue an interim rns at leadt to update shareholders? I have no issues waiting for good news!!
Never invest in a company that loan shares to shorters!!
Isn’t there a risk to the sharelender NOT getting their money back though, ie if the share rises. Or would the shorter have to somehow insure the borrower? Not a nice thing to do though.
I’m also starting to wonder why its taking soo long. Surely they either owe the money or not ?
Some interesting times ahead!! Firstly traumakine has to work...,, It’s a case then as to whether the sp goes up on YODA and partner results (I’d guesd it will , but by how much is anyones guess). Even if we have to wait 12 months for a multibagger , its not the end of the world.
It has been clear for a while that Clevergen doesn’t affect the share price at the moment. We had a good rns regarding Traumakine before Christmas and the share price fell!! Lets wait until YODA and a partner rns is released to see where the sp goes.
We know that Align works for Oilex - anyone know if they are reasonably accurate with their predictions based on past experience?
I’m in on this one as well, bought in at 29p. Fingers crossed over the next werks/months!
I think at the moment that around 50p is the minimum price, and seems to have spiked recently for some reason. Cant see it changing too much until we get some good news - hopefully in the next fee months (Q1). Dont expect much from the japanese trial. YODA is the one we want,